Understanding a Neuropathy Score of 7 out of 20
A neuropathy scale score of 7 out of 20 indicates mild peripheral neuropathy. 1
Score Interpretation
According to the European Myeloma Network guidelines, the Total Neuropathy Score (TNS) uses the following severity classification: 1
- Score 0: No peripheral neuropathy
- Score 1-9: Mild peripheral neuropathy
- Score 10-19: Moderate peripheral neuropathy
- Score ≥20: Severe peripheral neuropathy
Your patient's score of 7 falls within the mild neuropathy range. 1
What This Means Clinically
At this mild severity level, the patient likely experiences: 1
- Sensory symptoms limited to fingers or toes (not extending beyond)
- Minimal motor involvement with at most slight difficulty in movement
- Reduced sensation to pin or vibration testing confined to fingers and/or toes
- Preserved ankle reflexes or only mild reduction
- No significant functional disability from the neuropathy
The Total Neuropathy Score evaluates 10 different parameters including sensory symptoms, motor symptoms, autonomic symptoms, pin sensibility, vibration sensibility, strength, tendon reflexes, and nerve conduction studies. 1 Each parameter is scored 0-4, with higher scores indicating worse function.
Clinical Implications for Management
This mild neuropathy warrants active management to prevent progression. 2, 3
The priority at this stage is identifying and treating reversible causes: 2, 3
- Optimize glucose control if diabetic (most common cause in elderly patients) 2, 3
- Screen for vitamin B12 deficiency, thyroid dysfunction, and other metabolic causes 2
- Review medications that may cause neuropathy (chemotherapy agents, certain antibiotics) 1, 2
- Assess for alcohol use, renal disease, and infections (hepatitis B/C, HIV) 2
For symptomatic relief if the patient has neuropathic pain, first-line pharmacological options include duloxetine 60 mg daily, pregabalin, or gabapentin. 2 However, at a score of 7, many patients may not yet require pain medication if symptoms are minimal.
Monitoring and Prevention
Annual reassessment is essential to detect progression early, particularly in diabetic patients. 2, 3 The goal is preventing advancement to moderate or severe neuropathy, which carries significantly higher risk of falls, foot ulcers, and functional disability. 3, 4, 5
Physical activity should be encouraged as it has demonstrated benefit in improving neuropathic symptoms and preventing progression. 2